Plus   Neg

Boston Properties Lifts 2020 Profit View; Enters Into JV With Alexandria

Boston Properties Inc. (BXP) raised its fiscal year 2020 earnings per share outlook to a range of $5.91 - $6.09 per share from the prior range of $3.45 - $3.65 per share, primarily due to an estimated $2.37 per share in gains from sales of real estate. The sale is expected to close in the first quarter of 2020. Analysts polled by Thomson Reuters expect the company to report earnings of $3.59 per share for fiscal year 2020. Analysts' estimates typically exclude special items.

In addition, the company also increased its annual funds from operations per share outlook to a range of $7.47 - $7.65 per share from the previous outlook of $7.45- $7.65 per share, primarily due to lower than projected net interest expense.

The company said it expects earnings per share to be in the range of $3.22 - $3.24 and funds from operations of $1.80 - $1.82 per share for the first quarter 2020. Analysts project first-quarter earnings of $0.80 per share.

Separately, Boston Properties announced a joint venture with Alexandria Real Estate Equities Inc. (ARE) to develop, own and operate about 1.1 million square feet of existing office and lab properties in South San Francisco, California.

The joint venture will also have an opportunity to expand the campus through about 640,000 square feet of future development.

The joint venture expects to own a 1.7 million square foot life science campus, including a mix of office and lab buildings. Boston Properties and Alexandria will each have an approximately 50% ownership in the joint venture once complete.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Marriott International announced a security data breach at its property system that hit up to approximately 5.2 million guests. The breached information is believed to exclude Marriott Bonvoy account passwords or PINs, payment card information, passport information, national IDs, or driver's license numbers. The latest incident, however, is less severe compared to the hotel chain's 2018 data breac The U.S. Food and Drug Administration granted approval for Coagulation Factor VIIa (Recombinant) to biopharmaceutical company LFB S.A. for the treatment and control of bleeding episodes occurring in adults and adolescents - 12 years of age and older- with hemophilia A or B with inhibitors. It is marketed as Sevenfact by LFB. Chipotle Mexican Grill, Inc. is giving away 100,000 burritos to healthcare workers, who are at present fighting in the front line against coronavirus or Covid-19 pandemic. The food chain has asked healthcare teams to submit their application by Thursday, April 2, which is this year's National Burrito day. The offer is valid for a free preconfigured Burritos by the Box order of 25 burritos.
Follow RTT